Jones V E, Leskowitz S
J Exp Med. 1965 Sep 1;122(3):505-15. doi: 10.1084/jem.122.3.505.
Injections of various conjugates of arsanilic acid into newborn guinea pigs produced a specific tolerance in respect to subsequent development of hapten-specific delayed hypersensitivity. In general, larger polyvalent conjugates produced longer lasting and more profound suppression of delayed sensitivity than did the smaller ones. Carrier injections alone were ineffective. At lower doses of conjugate, breakthrough of tolerance occurred first with animals immunized with the heterologous carrier conjugate. The duration of tolerance produced by injection of monovalent conjugates into neonates is in contrast to the transient inhibition produced by the same conjugates in previously sensitized animals, suggesting that different target cells may be involved in these two phenomena.
将各种对氨基苯胂酸结合物注射到新生豚鼠体内,可使其对随后发生的半抗原特异性迟发型超敏反应产生特异性耐受。一般来说,较大的多价结合物比小的结合物对迟发型超敏反应的抑制作用更持久、更显著。单独注射载体则无效。在较低剂量的结合物情况下,对用异源载体结合物免疫的动物,首先出现耐受突破。将单价结合物注射到新生动物体内所产生的耐受持续时间,与相同结合物在先前致敏动物中产生的短暂抑制形成对比,这表明这两种现象可能涉及不同的靶细胞。